Cytokinetics closes $500M public equity offering; concurrent $50M private placement

CYTOKINETICS INC

Closed public offering of 9,803,922 shares at $51.00; gross proceeds ~$500M.
Underwriters have 30-day option for additional 1,470,588 shares; potential $575M total.
Concurrent private placement to Royalty Pharma for 980,392 shares at $51.00 per share.
Offering led by J.P. Morgan, Goldman Sachs, and Morgan Stanley; closed May 28, 2024.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.